Pharmaceutical inhibition of mTOR in the common marmoset: effect of rapamycin on regulators of proteostasis in a non-human primate.
What this study shows
In liver and skeletal muscle from rapamycin-treated marmosets (the earlier pilot cohort), rapamycin was associated with higher expression of PSMB5, a core 20S proteasome subunit, in both tissues but not of PSMB8; proteasome activity itself did not change. Mitochondria-targeted chaperones rose in skeletal muscle but not liver, and autophagy rose in skeletal muscle and adipose tissue but not liver. The authors conclude that only some components of the proteostasis network were upregulated, and in a tissue-specific way. Boundary: tissue samples from a small pilot cohort; the changes are expression-level associations and are not shown to cause any health or lifespan effect.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Common marmoset (Callithrix jacchus), oral rapamycin, liver, skeletal muscle and adipose tissue from a pilot cohort); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Common marmoset (Callithrix jacchus), oral rapamycin, liver, skeletal muscle and adipose tissue from a pilot cohort |
| Journal | Pathobiology of Aging & Age-related Diseases |
| Year | 2016 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.3402/pba.v6.31793 · PMID 27341957 · Free full text (PMC4920937) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Oral rapamycin (pilot cohort) |
| Target | Proteostasis network: proteasome (PSMB5), mitochondrial chaperones, autophagy |
| Model | Common marmoset (Callithrix jacchus) |
| Effect | Tissue-specific: higher PSMB5 and mitochondrial chaperones in muscle, higher autophagy in muscle and adipose, no change in proteasome activity or in liver autophagy |
In the Atlas
Related topics
More studies on this topic
- Molecular switches of SQSTM1: the impact of post-translational modifications on autophagy and neurodegeneration (2026)
- Strengthening Muscle for Healthy Ageing: Innovative Treatments for Sarcopenia (2026)
- Rapamycin alleviates toxicity of different aggregate-prone proteins (2006)
- Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster (2010)
Thank you. Your answer was counted anonymously.